Archimedes touts late-stage data; Harvard gets $125M for biological engineering;

> The UK's Archimedes Pharma is reporting positive late-stage data for its fentanyl citrate nasal spray, developed to provide fast, effective and convenient treatment for breakthrough cancer pain. Researchers said that NasalFent hit its primary endpoint. Patients treated with NasalFent showed a statistically significant improvement in summary of pain intensity difference at 30 minutes compared to placebo, meaning a greater reduction in pain. Archimedes release [1]

> In the largest individual gift Harvard University has ever received, billionaire alumni Hansjörg Wyss has donated $125 million for the establishment of a biological engineering institute. Harvard report [2]

> Once again, Pfizer faces allegations of Neurontin mismarketing. Experts analyzed internal company documents made public in a lawsuit, concluding that Pfizer marketers put a positive spin on negative research. Pfizer report [3]

> Researchers at Wake Forest University are developing a nanotech process which could potentially speed the search for new anti-cancer drugs. Report [4]

> Swedish biotech company Q-Med will discontinue its in-house development of new products within Hospital Healthcare, shedding 50 jobs at its facility in Uppsala, Sweden. Q-Med release [5]

> Novo Nordisk has transferred a portfolio of inhaled insulin related patents to Aradigm at no cost. Novo purchased a significant portion of the portfolio from Aradigm in July 2006 and supplemented the portfolio with certain of its own related patents. Novo Nordisk release [6]

> Just when it looked as if things were calming down at Canada's Biovail, shareholders have filed a new class action suit. Report [7]

> A new vaccine developed by a Swedish team of scientists may help children and adolescents diagnosed with Type 1 diabetes better manage the disease. Report [8]

> The FDA has issued a warning letter to Bayer for two commercials, "Not Gonna Take It" and "Balloons," for its birth control pill, Yaz. Report [9]

And Finally... The campaign against sports cheats has found a new ally in Big Pharma. Roche says it collaborated with anti-doping experts to help catch Tour de France athletes who used its anemia drug Mircera [10]--known as CERA in sports circles--to boost their cycling performance. Report [11]